3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Classical hematology
1
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
4
Neoplasms
4
Neutropenia
3
Lymphoma, Non-Hodgkin
3
Leukemia, Myeloid, Acute
3
Febrile Neutropenia
3
Urinary Bladder Neoplasms
2
Sezary Syndrome
2
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
2
Myelodysplastic Syndromes
2
Mycosis Fungoides
2
Lymphoma, T-Cell, Cutaneous
2
Lymphoma, Mantle-Cell
2
Lymphoma, Large-Cell, Immunoblastic
2
Lymphoma, Large-Cell, Anaplastic
2
Lymphoma, Large B-Cell, Diffuse
2
Lymphoma, Follicular
2
Lymphoma, B-Cell, Marginal Zone
2
Lymphoma
2
Leukemia, Lymphocytic, Chronic, B-Cell
2
Leukemia, Biphenotypic, Acute
2
Intraocular Lymphoma
2
Infections
2
Immunoblastic Lymphadenopathy
2
Hodgkin Disease
2
Burkitt Lymphoma
2
Urinary Tract Infections
1
Testicular Neoplasms
1
Testicular Germ Cell Tumor
1
Stem Cell Transplant Complications
1
Interventions
telavancin
1
soybean oil, phospholipid emulsion
1
drotrecogin alfa activated
1
Trimethoprim, Sulfamethoxazole Drug Combination
1
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization
1
Simvastatin
1
Saline Solution
1
Povidone-Iodine
1
Methods
1
Meropenem
1
Massage
1
Levofloxacin
1
Hydrochloric Acid
1
Granulocyte-Macrophage Colony-Stimulating Factor
1
Gentamicins
1
Colistin
1
Colchicine
1
ClinOleic
1
Anti-Bacterial Agents
1
Amoxicillin-Potassium Clavulanate Combination
1
Alkaline Phosphatase
1
Acupuncture Therapy
1
2-Propanol
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Sepsis
×
Levofloxacin
×
Clear all
NCT05393505
2022-12-06
FRANCiS-NF
The University of Hong Kong
Phase 4
Unknown
344 enrolled